Results 1 to 10 of about 20,917 (165)
Zhongshan Daxue xuebao. Yixue kexue ban, 2006 【目的】探讨影响分化型甲状腺癌（differentiated thyroid carcinoma，DTC）预后的因素。【方法】回顾性收集1985年1月1日至1997年12月31日在中山大学肿瘤防治中心治疗的分化型甲状腺癌581例，对其预后进行单因素和多因素分析。【结果】581例分化型甲状腺癌的5、10、15年生存率分别为93．6％、87．5％和80．6％。单因素分析显示影响分化型甲状腺癌预后的因素有性别、年龄、肿瘤大小、T分期、远处转移、治疗方式、复发和临床病理分期，P〈0．05，病理类型 ...
陈福进 +7 more
doaj +2 more sources
错配修复蛋白hMLH1在子宫内膜癌表达的临床意义 [PDF]
Zhongshan Daxue xuebao. Yixue kexue ban, 2005 【目的】 探讨错配修复蛋白hMLH1在子宫内膜癌(endometrial carcinoma，EC)的失表达情况及其临床意义。【方法】 用免疫组化S-P方法检测hMLH1蛋白在61例子宫内膜癌组织的失表达情况，并分析hMLH1蛋白失表达与子宫内膜癌临床病理的关系。【结果】 子宫内膜癌组织存在hMLH1蛋白失表达，其失表达率为29.5％。hMLH1失表达子宫内膜癌细胞分化较好(P=0.047)，临床预后较好(OR=5.458，P=0.025)，hMLH1失表达为子宫内膜癌独立预后因素(Cox多因素分析，P=
林美芳
doaj +2 more sources
Zhongguo cuzhong zazhi, 2022 目的 分析首次青年缺血性卒中患者出院、发病90d预后不良的相关危险因素。 方法 回顾性纳入18～45岁、发病72 h内的首次缺血性卒中患者，收集患者人口学信息、血管危险因素、实验室检查结果、入院和出院时NIHSS，以出院时和发病90 d mRS≥2分为预后不良，分别比较预后不良组和预后良好组危险因素的差异和病因分型特点，并采用多因素logistic回归分析出院和90 d预后不良的独立危险因素。 结果 研究共纳入691例首次青年缺血性卒中患者，出院预后不良234例（33.9%），90 ...
刘艳芳, 贾娇坤, 赵性泉
doaj +1 more source
Systematic Review of the Spine Patient Outcome Research Trial for Patients with Lumbar Spinal Stenosis [PDF]
, 2022 BackgroundLumbar spinal stenosis (LSS) is the main cause of severe pain and disability. The long-term prognosis of surgical intervention for LSS is still controversial, and the reoperation rate is high.
ZHOU Yanji, LIU Changxin, LIU Yangang, WANG Xiyou, AN Yi, YUAN Yi, LI Duoduo, YU Changhe
core +1 more source
Impact of body dose parameters on circulating immune cells in locally advanced nasopharyngeal carcinoma patients: a retrospective cohort study [PDF]
, 2023 Background and purpose: The implementation of intensity-modulated radiotherapy (IMRT) has significantly enhanced the survival outcomes for patients with nasopharyngeal carcinoma (NPC).
JIANG Jianyun, ZHAI Ruiping, YING Hongmei
core +1 more source
The prognostic value of high expression of FKBP1A in gastric cancer and the regulatory effect of targeted PI3K/AKT on glucose metabolism [PDF]
, 2023 Background and purpose: Gastric cancer is one of the common gastrointestinal malignancies. FKBP1A has been reported to be involved in the occurrence and development of various tumors, but the biological role and mechanism of it in gastric cancer remain ...
SUN Yang, WANG Lian, ZHAO Meng, ZHANG Xiaofeng, GENG Zhijun, WANG Yueyue, SONG Xue, ZUO Lugen, LI Jing, HU Jianguo
core +1 more source
The efficacy and prognosis analysis after stereotactic body radiotherapy for multiple primary early-stage lung cancer [PDF]
, 2023 Background and purpose: More and more patients with multiple primary early-stage lung cancer are choosing to receive stereotactic body radiation therapy (SBRT), and this study aimed to retrospectively analyze the efficacy and prognostic factors of SBRT ...
WU Han, YANG Zhangru, FENG Wen, ZENG Wanqin, GUO Jindong, LI Hongxuan, WANG Changlu, WANG Jiaming, LÜ Changxing, ZHANG Qin, YU Wen, CAI Xuwei, FU Xiaolong
core +1 more source
Zhongguo shiyan zhenduanxue, 2021 目的分析血浆凝血因子VⅢ(FⅧ)对IgA肾病患者不良预后的预测价值。方法回顾性收集2017年4月至2018年5月就诊于沧州市中心医院的原发性IgAN患者共84例,收集所有研究对象的临床资料,包括一般情况(年龄、性别、病史、体质指数、血压)、24h尿蛋白量及血生化指标等,随后进行为期3年的随访。利用Spearman相关法分析血浆FⅧ水平与临床指标的相关性。采用单因素Cox回归分析建立模型并计算风险比值(HR),多因素Cox回归分析进行矫正,明确独立危险因素 ...
孙景毅, 赵楠, 潘红梅, 张浩然
doaj
Analysis of efficacy of hepatectomy and prognostic risk factors in patients with gastric cancer with synchronous liver metastasis [PDF]
, 2023 Background and purpose: Whether patients with gastric cancer with synchronous liver metastases (GCLM) receive hepatectomy remains controversial. In this study, we analyzed the clinicopathological characteristics and treatment modalities of patients with ...
ZOU Ting, LIU Xiaowen
core +1 more source
18F-FDG PET/CT预测弥漫大B细胞淋巴瘤化疗后无进展生存期
Zhongshan Daxue xuebao. Yixue kexue ban, 2023 目的评估18F-FDG PET/CT不同代谢参数在分析弥漫性大B细胞淋巴瘤（DLBCL）治疗响应中的预测价值。方法回顾性地选取2015年6月至2020年10月收治18F-FDG PET/CT的81例DLBCL患者。通过多元逻辑回归分析确定DLBCL治疗反应的预测因素，并根据这些因素创建预测模型。之后，通过特性曲线和校准图验证此预测模型的性能。结果首次化疗后2年内，23例患者（28.3%，23/81）疾病复发，58例患者（71.7%，58/81）无进展。本文分析了PET ...
林少春 +4 more
doaj